FASTinov will be present at the ECCMID congress in Copenhagen, Denmark, on 15-18 April 2023

• ricardo
• March 15, 2023
• Clinical Microbiology & Infectious Diseases, congress, ECCMID
• 0

FASTinov will be present at the ECCMID congress in Copenhagen, Denmark, on 15-18 April 2023

FASTinov will be present at the upcoming 33nd European Congress of Clinical Microbiology & Infectious Diseases, which will take place in Copenhagen, Denmark on April 15-18.

The company has started the commercialization of its ultra-rapid Antibiotic Susceptibility Testing technology capable of establishing phenotypic susceptibility in less than two hours directly from blood cultures.

“The field of antimicrobial susceptibility testing is experiencing a revolution. Determining phenotypic susceptibility in 2-hours from blood cultures has the potential to change the response to bloodstream infectious. ECCMID is the largest Clinical Microbiology & Infectious Diseases event in the world and the thousands of experts attending come precisely to learn about these technological breakthroughs
said Ricardo Sousa, who leads FASTinov’s commercial operations

FASTinov will be at stand EN-05. Come visit us!

About FASTinov

FASTinov has developed ultra-rapid, phenotypic antibiotic susceptibility tests for bloodstream infections that deliver antibiograms in less than 2 hours, based upon patented technologies. The company is based in Porto, Portugal.
For press inquiries, please contact: info@fastinov.com

• For press inquiries, please contact: info@fastinov.com